Identification of immune-related molecular clusters and diagnostic markers in chronic kidney disease based on cluster

Peng Yan1, Ben Ke1, Jianling Song1

  • 1Department of Nephrology, The Second Affiliated Hospital of Nanchang University, Nanchang, China.

Frontiers in Genetics
|February 23, 2023
PubMed

Insights

This study identified two distinct immune subtypes in chronic kidney disease (CKD) and developed a predictive model using five key genes. Three markers, LYZ, CTSS, and ISG20, show potential for diagnosing CKD and understanding its immune microenvironment.

Area of Science:

  • Immunology
  • Genomics
  • Nephrology

Background:

  • Chronic kidney disease (CKD) is a complex condition with varied causes and outcomes.
  • Understanding the immune landscape of CKD is crucial for identifying distinct patient subgroups.
  • Identifying reliable diagnostic markers is essential for improved CKD management.

Purpose of the Study:

  • To classify chronic kidney disease (CKD) into immune-related molecular clusters.
  • To investigate the functional immunological properties of these clusters.
  • To identify novel diagnostic markers for CKD subtypes.

Main Methods:

  • Weighted gene co-expression network analysis (WGCNA) to identify core immune-related genes (IRGs).
  • Unsupervised clustering to stratify 440 CKD patients into two immune subclusters.
  • Machine learning (LASSO, RF, SVM-RFE) and Venn diagrams to select five signature IRGs for a diagnostic nomogram model.
  • CIBERSORT and Nephroseq V5 to analyze immune cell infiltration and correlation with renal function.

Main Results:

  • Two distinct immune-related molecular clusters were identified in CKD patients.
  • Cluster 2 exhibited enriched immune functions (leukocyte adhesion, immune activation) and a poorer immune prognosis.
  • A nomogram model based on five signature genes accurately predicted CKD immune clusters.
  • LYZ, CTSS, and ISG20 were identified as key diagnostic markers linked to immune microenvironment and renal function.

Conclusions:

  • This study successfully classified CKD into two subtypes based on immune gene expression patterns.
  • A novel nomogram model offers reliable prediction of these immune-related CKD subtypes.
  • The identified markers LYZ, CTSS, and ISG20 hold promise for CKD diagnosis and therapeutic target exploration.

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
52
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
66
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
56
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
49
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
51
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
36